NanoVation Therapeutics™
nanovation therapeutics™ (ntx) develops customized nucleic acid and lipid nanoparticle technologies to empower its partners’ genetic medicines. by enabling the safe and efficacious delivery of nucleic acids to a variety of tissues, ntx’s unique toolbox can rapidly advance therapeutic concepts into clinical reality. ntx is delivering tomorrow's genetic medicines, today™.
Last updated on
About NanoVation Therapeutics™
Founded
2020Employees
11-50Funding / Mkt. Cap
$300KCategory
Location
City
VancouverState
British ColumbiaCountry
CanadaNanoVation Therapeutics™
Find your buyer within NanoVation Therapeutics™